Cochlear Limited · ASX:COH
Michael del Prado bought 235 Cochlear Limited shares (Appendix 3Y, ASX)
Traded Nov 16, 2026 · Filed Nov 18, 2026
On Nov 16, 2026, Michael del Prado (Director) bought 235 Cochlear Limited shares at US$102.26 for US$24,031. Filed Nov 18, 2026 (Appendix 3Y, ASX).
- Bought
- 235 shares
- Price
- US$102.26
- Value
- US$24,031
- Role
- Director
The filing in full
*Rule 3.19A.2*
Appendix 3Y
Change of Director’s Interest Notice
*Information or documents not available now must be given to ASX as soon as available. Information and
documents given to ASX become ASX’s property and may be made public.*
Introduced 30/09/01 Amended 01/01/11
| Name of entity | Cochlear Limited |
|---|---|
| ABN | 96 002 618 073 |
We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for
the director for the purposes of section 205G of the Corporations Act.
| Name of Director | Michael del Prado |
|---|---|
| Date of last notice | 27 August 2026 |
Part 1 - Change of director’s relevant interests in securities
*In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust*
Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be
disclosed in this part.
| Direct or indirect interest | Direct |
|---|---|
| Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest. | Not applicable |
| Date of change | 16 November 2026 |
| No. of securities held prior to change | 1,504 Shares |
| Class | Fully Paid Ordinary Shares in Cochlear Limited (“Shares”) |
| Number acquired | 235 Shares |
| Number disposed | - |
| Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation | US$102.26 per Share |
| No. of securities held after change | 1,739 Shares |
---
Nature of changeExample: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-backPurchase of Shares on the United States over-the-counter (OTC) market
Part 2 – Change of director’s interests in contracts
Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be
disclosed in this part.
| Detail of contract | N/A |
|---|---|
| Nature of interest | N/A |
| Name of registered holder (if issued securities) | N/A |
| Date of change | N/A |
| No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed | N/A |
| Interest acquired | N/A |
| Interest disposed | N/A |
| Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation | N/A |
| Interest after change | N/A |
+ Part 3 – Closed period
| Were the interests in the securities or contracts detailed above traded during a +closed period where prior written clearance was required? | No |
|---|---|
| If so, was prior written clearance provided to allow the trade to proceed during this period? | N/A |
| If prior written clearance was provided, on what date was this provided? | N/A |
- See chapter 19 for defined terms.
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Nov 16, 2026 | Fully Paid Ordinary Shares in Cochlear Limited (“Shares”) | Buy | 235 | US$102.26 |
Source
Download PDF · View original at ASX